Dr. Rashmi Halker Singh, MD, FAHS, FAAN, has been an integral part of the American Migraine Foundation Editorial Board for an extended period, demonstrating a steadfast dedication to the foundation’s mission and goals. Her extensive expertise and unwavering commitment have consistently contributed to the board’s efforts in advancing migraine research, education, and advocacy. She became a headache neurologist because she was inspired to connect with her patients. Working with AMF in this role, advocating for patients and sharing information about migraine and other headache disorders, is another way of doing that. 

 

“It is such a prevalent problem and impacts people in so many different ways. There’s lots of groundbreaking research going on and being able to share that with people who are affected by it is really important,” said Dr. Halker Singh. “The AMF is really doing a great job of distilling down that knowledge and really sharing the latest research and science to those who really need it the most.”

 

She serves as Secretary on the Board of Directors of the American Headache Society and is involved in the International Headache Society. Dr. Halker Singh is also very active at the Mayo Clinic where she is an Associate Professor of Neurology and also serves as the headache medicine fellowship program director, neuroscience block faculty member at Mayo Medical School, and the co-director of the Mayo Clinic Headache Symposium. 

 

Dr. Halker Singh believes people learn in different ways, through various mediums and have varied interests. She says, some want to read a clip on social media, some want to read the latest research, others want to hear what experts say, while some want to build community. AMF can broaden its reach by trying different things and having a board that represents all the people it is trying to reach. It can do that by having experts that feel comfortable in many modalities. Continued advocacy is also critical. 

 

“I think advocacy is important because it can help drive change,” said Dr. Halker Singh. “ I think that’s really the bottom line. And we really need everyone involved with that.”

 

Dr. Halker Singh is very hopeful about what is happening in migraine right now, as scientists and doctors are really beginning to understand more about the disease. She says there is a better understanding today of how to take care of people who live with migraine. There is research happening around new medications, and also into non-medication strategies as well. This includes neuromodulation, biosocial aspects and individualizing treatment. 

 

“I think the most exciting thing is our deepened understanding of what migraine really is from a disease process that has been leading to so many new treatments and ways of treating migraine,” said Dr. Halker Singh. “I’m not just talking about the new medications that have evolved, but this multimodal approach to treating migraine.”